Dutch MPs approve bill to grow embryos for medical research

The Tweede Kamer, the lower house of Dutch parliament, has approved the D66 and VVD bill permitting embryos to be grown for scientific research. The initiators of the bill hope it will result in medical advances, enhancing IVF procedures and allowing hereditary diseases to be detected earlier. Prior to the vote, ChristenUnie and SGP voiced strong opposition to the proposal.

Because the topic was sensitive for certain parties, ChristenUnie requested a roll-call vote. This allowed each member of parliament to cast their vote on the proposal individually.

Henri Bontenbal stated ahead of the vote that CDA had wrestled with the proposal and debated it extensively. In the end, most Christian Democrats voted in favor, but the party leader stressed that, given the moral sensitivity of the issue, CDA MPs were free to oppose the bill, a choice some members exercised.

Following the vote, CDA posted a comprehensive explanation on its website outlining why most of its members supported the bill. “We recognize that this law may be at odds with the sanctity of early life. However, we also believe that, when done extremely carefully, preventing serious suffering and saving lives can outweigh these concerns,” the statement concludes.

The bill was approved by a significant majority, with 90 MPs voting in favor and 59 voting against. The bill will next be discussed and voted on by the Eerste Kamer, the Dutch Senate.

Mirjam Bikker of ChristenUnie defended her opposing vote by saying, “This law opens a door, and we cannot fully predict what will come through it.” Diederik van Dijk of SGP added that the proposal “treats early human life as mere test material” and argued, “In doing so, we encroach on a power reserved for our Creator, the author of life.”

During last week’s coalition formation debate, ChristenUnie and SGP signaled that their readiness to work with a future coalition would, in part, be influenced by how the vote on this bill turned out.

The Dutch Patients Association (NPV) expressed disappointment with the decision, according to director Bert-Jan Heusinkveld. “This marks a shift. Life is being cultivated for instrumental purposes. The focus is no longer on the embryo’s life itself, but on its role in scientific research,” he said.

Heusinkveld acknowledges that the research aims, like preventing hereditary diseases, can be worthwhile. “However, the goal does not justify the means. I understand the need for research, but should human lives be sacrificed for it? That is effectively what is happening. This law allows us to decide which embryos are allowed to develop and which are treated as instruments. It concerns developing human life.”